PharmaRoth Labs, Inc. announced that it has entered into a definitive agreement with Marcas De Renombre, S.A. De C.V.granting Marcas exclusive rights for the commercialization and distribution of Sucanon(R) in Mexico. The agreement is for 50 years with annual sales increases conditional for continuance of exclusivity, with the first shipment anticipated in June.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2015 | PharmaRoth Labs, Inc. Receives Additional Order from Marcas de Renombre | CI |
2014 | PharmaRoth Labs, Inc. Announces New Distribution Agreement with Biotechnology Co., Ltd | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 390 | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ROTH Stock
- News PharmaRoth Labs, Inc.
- PharmaRoth Labs, Inc. Signs Definitive Distribution Agreement in Mexico with Marcas De Renombre